Glycemic Thresholds for Diabetes-Specific Retinopathy
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 26 of the 26 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To re-evaluate the relationship between glycemia and diabetic retinopathy. RESEARCH DESIGN AND METHODS: We conducted a data-pooling analysis of nine studies from five countries with 44,623 participants aged 20–79 years with gradable retinal photographs. The relationship between diabetes-specific retinopathy (defined as moderate or more severe retinopathy) and three glycemic measures (fasting plasma glucose [FPG; n = 41,411], 2-h post oral glucose load plasma glucose [2-h PG; n = 21,334], and A1C [n = 28,010]) was examined. RESULTS: When diabetes-specific retinopathy was plotted against continuous glycemic measures, a curvilinear relationship was observed for FPG and A1C. Diabetes-specific retinopathy prevalence was low for FPG <6.0 mmol/l and A1C <6.0% but increased above these levels. Based on vigintile (20 groups with equal numbers) distributions, glycemic thresholds for diabetes-specific retinopathy were observed over the range of 6.4–6.8 mmol/l for FPG, 9.8–10.6 mmol/l for 2-h PG, and 6.3–6.7% for A1C. Thresholds for diabetes-specific retinopathy from receiver-operating characteristic curve analyses were 6.6 mmol/l for FPG, 13.0 mmol/l for 2-h PG, and 6.4% for A1C. CONCLUSIONS: This study broadens the evidence based on diabetes diagnostic criteria. A narrow threshold range for diabetes-specific retinopathy was identified for FPG and A1C but not for 2-h PG. The combined analyses suggest that the current diabetes diagnostic level for FPG could be lowered to 6.5 mmol/l and that an A1C of 6.5% is a suitable alternative diagnostic criterion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, evidence indicates that HbA1c, or fasting glucose, are stronger predictors of vascular complications than 2 h OGTT and it is therefore best to adopt these simple measures for general screening, particularly given their high reproducibility.[35][36][37][38]”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
(1991) · Ophthalmology · doi:10.1016/s0161-6420(13)38012-9 · Cited by 2,048
Unwin, N. C. (2006) · Cited by 1,661
Full accounting of diabetes and pre-diabetes in the U.S. population in 1988–1994 and 2005–2006
Cowie, C. C., Rust, K. F., Ford, E. S., Eberhardt, M. S., Byrd-Holt, D. D., Li, C., Williams, D. E., Gregg, E. W., Bainbridge, K. E., Saydah, S. H., et al. (2009) · Diabetes Care · doi:10.2337/dc08-1296 · Cited by 1,154 · cited 1×
“This has been an ongoing issue with the current diagnostic criteria whereby using FPG alone or an OGTT to diagnose diabetes, give different diabetes prevalence (23).”
BackgroundDiabetic Retinopathy in a Multi-ethnic Cohort in the United States
Wong, T. Y., Klein, R., Islam, F. M. A., Cotch, M. F., Folsom, A. R., Klein, B. E. K., Sharrett, A. R., & Shea, S. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.08.063 · Cited by 684 · cited 1×
“All nine studies measured plasma glucose, and six studies that measured A1C used high-performance liquid chromatography, of which five used a Diabetes Control and Complicat ions Trial (DCCT)-aligned assay (5,12,14,15,18).”
MethodSelf-citationMcCane, D. R., Hanson, R. L., Charles, M. A., Jacobsson, L. T. H., Pettitt, D. D., Bennett, P. H., & Knowler, W. C. (1994) · BMJ · doi:10.1136/bmj.308.6940.1323 · Cited by 484
Harris, M. I., Klein, R., Cowie, C. C., Rowland, M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.8.1230 · Cited by 401 · cited 2×
“All nine studies measured plasma glucose, and six studies that measured A1C used high-performance liquid chromatography, of which five used a Diabetes Control and Complicat ions Trial (DCCT)-aligned assay (5,12,14,15,18).”
BackgroundMethod
Research works printed but not linked: 2
- Colagiuri, 2003, DETECT-2: early detection of type 2 diabetes and IGT, Diabetes Voice, 48, 11
- Diabetic Retinopathy Study Research Group, 1981, Report 7. A modification of the Airlie House classification of diabetic retinopathy, Invest Ophthalmol Vis Sci, 21, 210
Cited by
Cosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz486 · Cited by 4,763
Chatterjee, S., Khunti, K., & Davies, M. J. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30058-2 · Cited by 2,577
The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives
Chen, L., Magliano, D. J., & Zimmet, P. Z. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.183 · Cited by 2,227
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht108 · Cited by 1,955
2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes.
Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R. A., Antunes, M. J., Christodorescu, R. M., Crawford, C., Di Angelantonio, E., Eliasson, B., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad192 · Cited by 1,642
Type 2 diabetes across generations: from pathophysiology to prevention and management
Nolan, C. J., Damm, P., & Prentki, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60614-4 · Cited by 923
Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome
Punthakee, Z., Goldenberg, R., & Katz, P. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.003 · Cited by 877
Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome
Goldenberg, R., & Punthakee, Z. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.011 · Cited by 611
(2014) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.10.013 · Cited by 609
Fox, C. S., Golden, S. H., Anderson, C., Bray, G. A., Burke, L. E., de Boer, I. H., Deedwania, P., Eckel, R. H., Ershow, A. G., Fradkin, J., et al. (2015) · Diabetes Care · doi:10.2337/dci15-0012 · Cited by 492
Fox, C. S., Golden, S. H., Anderson, C., Bray, G. A., Burke, L. E., de Boer, I. H., Deedwania, P., Eckel, R. H., Ershow, A. G., Fradkin, J., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000230 · Cited by 386
Schlesinger, S., Neuenschwander, M., Barbaresko, J., Lang, A., Maalmi, H., Rathmann, W., Roden, M., & Herder, C. (2022) · Diabetologia · doi:10.1007/s00125-021-05592-3 · Cited by 327
Selvin, E., Rawlings, A. M., Grams, M., Klein, R., Sharrett, A. R., Steffes, M., & Coresh, J. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70199-2 · Cited by 262
Epidemiology of polyneuropathy in diabetes and prediabetes
(2014) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-53480-4.00001-1 · Cited by 235
Self-citationNeuropathy in prediabetes: does the clock start ticking early?
Papanas, N., Vinik, A. I., & Ziegler, D. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.113 · Cited by 212
Review of methods for detecting glycemic disorders
Bergman, M., Abdul-Ghani, M., DeFronzo, R. A., Manco, M., Sesti, G., Fiorentino, T. V., Ceriello, A., Rhee, M., Phillips, L. S., Chung, S., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108233 · Cited by 199
“This decision was based on the DETECT-2 study [20] examining pooled data from 44,623 patients in 12 different studies which found that the incidence of proliferative diabetic retinopathy increased significantly at this threshold.”
MethodHbA1c as a Diagnostic Test for Diabetes Mellitus - Reviewing the Evidence.
Florkowski, C. M. (2013) · Europe PMC (PubMed Central) · Cited by 195
Danaei, G., Fahimi, S., Lu, Y., Zhou, B., Hajifathalian, K., Di Cesare, M., Lo, W., Reis-Santos, B., Cowan, M., Shaw, J., et al. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00129-1 · Cited by 191
Self-citationBuysschaert, M., & Bergman, M. (2011) · Medical Clinics of North America · doi:10.1016/j.mcna.2010.11.002 · Cited by 176
Kassahun, T., Eshetie, T., & Gesesew, H. (2016) · BMC Research Notes · doi:10.1186/s13104-016-1896-7 · Cited by 135
“Previous studies assured that poor glycemic control correlated with enlarged risk of visual impairment [10], enlarged risk of kidney failure [11], and enlarged risk of cardiovascular disease [12].”
BackgroundScreening for type 2 diabetes: a short report for the National Screening Committee
Waugh, N., Shyangdan, D., Taylor-Phillips, S., Suri, G., & Hall, B. (2013) · Health Technology Assessment · doi:10.3310/hta17350 · Cited by 130
“5% suggested by the DETECT-2 Group.(21) The ADA position statement(69) in January 2010 recommended a cut-off of 6.”
BackgroundDiabetes Prevention Program Research Group (2015) · Diabetes Care · doi:10.2337/dc14-0886 · Cited by 139
Current controversies in the use of haemoglobin A1c
Hare, M. J. L., Shaw, J. E., & Zimmet, P. Z. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2012.02513.x · Cited by 106
Self-citationMansour, A. A., Al-Maliky, A. A., Kasem, B., Jabar, A., & Khalid, A. M. (2014) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s59652 · Cited by 133
Blagosklonny, M. V. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.506 · Cited by 116
Perreault, L., Pan, Q., Schroeder, E. B., Kalyani, R. R., Bray, G. A., Dagogo-Jack, S., White, N. H., Goldberg, R. B., Kahn, S. E., Knowler, W. C., et al. (2019) · Diabetes Care · doi:10.2337/dc19-0244 · Cited by 106
Kaur, G., Lakshmi, P. V. M., Rastogi, A., Bhansali, A. K., Jain, S., Teerawattananon, Y., Bano, H., & Prinja, S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242415 · Cited by 123
“5% based on the findings of DETECT-2 study [16].”
BackgroundClassification and Diagnosis of Diabetes
GENUTH, S. M., Palmer, J. P., & Nathan, D. M. (2018) · Cited by 112
The role of HbA1c in the diagnosis of diabetes mellitus in Australia
D'Emden, M. C., Shaw, J. E., Colman, P. G., Colagiuri, S., Twigg, S. M., Jones, G. R. D., Goodall, I., Schneider, H. G., & Cheung, N. W. (2012) · Medical Journal of Australia · doi:10.5694/mja12.10988 · Cited by 87
Self-citationSobrin, L., Green, T. J., Sim, X., Jensen, R. A., Tai, E. S., Tay, W. T., Wang, J. J., Mitchell, P. L. R., Sandholm, N., Liu, Y., et al. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-7510 · Cited by 100
Self-citationDiabetic retinopathy and systemic factors
Frank, R. N. (2015) · Middle East African Journal of Ophthalmology · doi:10.4103/0974-9233.154388 · Cited by 99
Selvin, E. (2016) · Diabetes Care · doi:10.2337/dc16-0042 · Cited by 96
Oh, E., Yoo, T. K., & Park, E.-C. (2013) · BMC Medical Informatics and Decision Making · doi:10.1186/1472-6947-13-106 · Cited by 90
“The optimal cut-off points of the traditional indicators for DR prediction have been calculated on the basis of several population-based studies [8,10].”
MethodEvidence for current diagnostic criteria of diabetes mellitus
Kumar, R., Nandhini, L. P., Kamalanathan, S., Sahoo, J., & Vivekanadan, M. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i17.396 · Cited by 95
Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c
NCD Risk Factor Collaboration (NCD-RisC), Zhou, B., Sheffer, K. E., Bennett, J. E., Gregg, E. W., Danaei, G., Singleton, R. K., Shaw, J. E., Mishra, A., Lhoste, V. P. F., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02610-2 · Cited by 94
Self-citationDiabetes prevention: global health policy and perspectives from the ground
Bergman, M., Buysschaert, M., Schwarz, P. E. H., Albright, A. L., Narayan, K. M. V., & Yach, D. (2012) · Diabetes Management · doi:10.2217/dmt.12.34 · Cited by 89
Cortigiani, L., Rigo, F., Gherardi, S., Galderisi, M., Bovenzi, F., & Sicari, R. (2014) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2014.02.010 · Cited by 78
Classification of diabetes mellitus and other categories of glucose intolerance
Magliano, D. J., Zimmet, P., & Shaw, J. E. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch1 · Cited by 78
Self-citationLi, W., Song, Y., Chen, K., Ying, J., Zheng, Z., Qiao, S., Yang, M., Zhang, M., & Zhang, Y. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-050989 · Cited by 76
Selvin, E., Wang, D., Matsushita, K., Grams, M. E., & Coresh, J. (2018) · Annals of Internal Medicine · doi:10.7326/m18-0091 · Cited by 73
Tobe, S. W., Stone, J. A., Anderson, T. J., Bacon, S., CHENG, A. Y. Y., Daskalopoulou, S. S., Ezekowitz, J. A., Grégoire, J. C., Gubitz, G. J., Jain, R., et al. (2018) · Canadian Medical Association Journal · doi:10.1503/cmaj.180194 · Cited by 72
Definition and Classification of Diabetes and Prediabetes and Emerging Data on Phenotypes
Colagiuri, S. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2021.06.004 · Cited by 70
Self-citationEide, I. A., Halden, T. A. S., Hartmann, A., Åsberg, A., Dahle, D. O., Reisæter, A. V., & Jenssen, T. G. (2016) · Transplant International · doi:10.1111/tri.12757 · Cited by 68
“5% (≥48 mmol/mol) in type 2 diabetes was based on the relationship between HbA1c levels and the occurrence of retinopathy [16].”
BackgroundGuidance concerning the use of glycated haemoglobin (HbA1c) for the diagnosis of diabetes mellitus
dʼEmden, M. C., Shaw, J. E., Jones, G. R. D., & Cheung, N. W. (2015) · The Medical Journal of Australia · doi:10.5694/mja15.00041 · Cited by 64
Self-citationOptimal HbA1c cutoff for detecting diabetic retinopathy
Cho, N. H., Kim, T. H., Woo, S. J., Park, K. H., Lim, S. K., Cho, Y. M., Park, K. S., Jang, H. C., & Choi, S. H. (2013) · Acta Diabetologica · doi:10.1007/s00592-013-0452-3 · Cited by 64
Jiménez‐Maldonado, A., García‐Suárez, P. C., Rentería, I., Moncada‐Jiménez, J., & Plaisance, E. P. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165820 · Cited by 64
“5% are also good predictors of cardiovascular disease, microvascular complications and all-cause mortality [145,147,148].”
BackgroundDysglycaemia, vasculopenia, and the chronic consequences of diabetes
Gerstein, H. C., & Werstuck, G. H. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70025-1 · Cited by 61
Similarities and differences in early retinal phenotypes in hypertension and diabetes
Grosso, A., Cheung, N., Veglio, F., & Wong, T. Y. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283496655 · Cited by 61
Self-citationKowall, B., & Rathmann, W. (2013) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s39093 · Cited by 60
Rapamycin-Induced Glucose Intolerance: Hunger or Starvation Diabetes
Blagosklonny, M. V. (2011) · Cell Cycle · doi:10.4161/cc.10.24.18595 · Cited by 59
Cystic Fibrosis Related Diabetes
O'Shea, D. B., & O’Connell, J. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0511-3 · Cited by 56
Chattopadhyay, S., George, A., John, J., & Sathyapalan, T. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy233 · Cited by 56
Thewjitcharoen, Y., Elizabeth, A. J., Butadej, S., Nakasatien, S., Chotwanvirat, P., Wanothayaroj, E., Krittiyawong, S., Himathongkam, T., & Himathongkam, T. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0339-6 · Cited by 232
Sabanayagam, C., Khoo, E. Y. H., Lye, W. K., Ikram, M. K., Lamoureux, E. L., Cheng, C. Y., Tan, M. L. S., Salim, A., Lee, J., Lim, S.-C., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2498 · Cited by 48
Self-citationCohort Profile: The Hoorn Studies
Rutters, F., Nijpels, G., Elders, P. J. M., Stehouwer, C. D. A., van der Heijden, A. A. W. A., Groeneveld, L., Hart, L. M. ‘., Dekker, J. M., & Beulens, J. W. J. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyx227 · Cited by 51
No Ethnic Differences in the Association of Glycated Hemoglobin With Retinopathy
Bower, J. K., Brancati, F. L., & Selvin, E. (2013) · Diabetes Care · doi:10.2337/dc12-0404 · Cited by 48
Xing, F., Neeland, I. J., Gore, M. O., Ayers, C. R., Paixao, A. R. M., Turer, A. T., Berry, J. D., Khera, A., de Lemos, J. A., & McGuire, D. K. (2013) · Diabetes and Vascular Disease Research · doi:10.1177/1479164113514239 · Cited by 49
“16 Diabetes & Vascular Disease Research 11(1)”
BackgroundResultInfluentialChanging patterns of sexually transmitted infections in India.
Sharma, V., & Khandpur, S. (2004) · PubMed · Cited by 47
Vajravelu, M. E., & Lee, J. M. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1012-6 · Cited by 46
Tucker, L. A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072207 · Cited by 45
The prevalence of retinopathy in prediabetes: A systematic review
Kirthi, V., Nderitu, P., Alam, U., Evans, J. R., Nevitt, S. J., Malik, R. A., Hopkins, D., & Jackson, T. L. (2022) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2022.04.002 · Cited by 45
New Diabetes Diagnostic Threshold of Hemoglobin A1c and the 3-Year Incidence of Retinopathy
Tsugawa, Y., Takahashi, O., Meigs, J. B., Davis, R. B., Imamura, F., Fukui, T., Taylor, W. C., & Wee, C. C. (2012) · Diabetes · doi:10.2337/db12-0103 · Cited by 39
Mukai, N., Yasuda, M., Ninomiya, T., Hata, J., Hirakawa, Y., Ikeda, F., Fukuhara, M., Hotta, T., Koga, M., Nakamura, U., et al. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-45 · Cited by 42
Use of HbA1c in the diagnosis of diabetes
Farmer, A. A. (2012) · BMJ · doi:10.1136/bmj.e7293 · Cited by 42
Limitations of Hemoglobin A1c for the Diagnosis of Posttransplant Diabetes Mellitus
Eide, I. A., Halden, T. A. S., Hartmann, A., Åsberg, A., Dahle, D. O., Reisæter, A. V., & Jenssen, T. G. (2014) · Transplantation · doi:10.1097/tp.0000000000000376 · Cited by 41
The role of hemoglobin A1c in the assessment of diabetes and cardiovascular risk
Sandler, C. N., & McDonnell, M. E. (2016) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.83.s1.02 · Cited by 41
Glucose-Independent Ethnic Differences in HbA1c in People Without Known Diabetes
Hare, M. J. L., Magliano, D. J., Zimmet, P., Söderberg, S., Joonas, N., Pauvaday, V., Larhubarbe, J., Tuomilehto, J. O., Kowlessur, S., Alberti, K. G. M. M., et al. (2012) · Diabetes Care · doi:10.2337/dc12-1210 · Cited by 41
Self-citationRashed, A. A., Saparuddin, F., Rathi, D.-N. G., Nasir, N. N. M., & Lokman, E. F. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2021.793414 · Cited by 39
White, N. H., Pan, Q., Knowler, W. C., Schroeder, E. B., Dabelea, D., Chew, E. Y., Blodi, B., Goldberg, R. B., Pi-Sunyer, X., Darwin, C. H., et al. (2022) · Diabetes Care · doi:10.2337/dc22-0860 · Cited by 39
Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome
(2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.02.002 · Cited by 39
Reversing the tide — diagnosis and prevention of T2DM in populations of African descent
Utumatwishima, J. N., Chung, S. T., Bentley, A. R., Udahogora, M., & Sumner, A. E. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.127 · Cited by 38
Paddock, E., Looker, H. C., Piaggi, P., Knowler, W. C., Krakoff, J. A., & Chang, D. C. (2018) · Diabetes Care · doi:10.2337/dc17-1900 · Cited by 38
Nailfold capillaroscopy and deep learning in diabetes
Shah, R., Petch, J., Nelson, W., Roth, K., Noseworthy, M. D., Ghassemi, M., & Gerstein, H. C. (2023) · Journal of Diabetes · doi:10.1111/1753-0407.13354 · Cited by 37
Rydén, L., estable, G. D. T. D. L. S. E. D. C. S. D. Y. T. D. L. C. I., Grant, P. J., Anker, S. D., Berne, C., Cosentino, F., Danchin, N., Deaton, C., Escaned, J., Hammes, H. P., et al. (2014) · Revista Española de Cardiología · doi:10.1016/j.recesp.2013.10.015 · Cited by 37
Ray, S. L., Coulson, D. J., Yeoh, M. L. Y., Tamara, A., Latief, J. S., Bakhashab, S., & Weaver, J. U. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197217 · Cited by 36
“4%), also signifies the turning point for the development of diabetes and is commonly used to describe a prediabetes state associated with the development of microvascular complication [38,39].”
BackgroundButler, A. E., English, E., Kilpatrick, E. S., Östlundh, L., Chemaitelly, H. S., Abu-Raddad, L. J., Alberti, K. G. M. M., Atkin, S. L., & John, W. G. (2020) · Acta Diabetologica · doi:10.1007/s00592-020-01606-5 · Cited by 36
“Key studies contributing to the IEC/ADA/WHO diagnostic threshold decision were the results of the cross-sectional Evaluation of Screening and Early Detection Strategies for Type 2 Diabetes and Impaired Glucose Tolerance (DETECT-2) study [9] and three epidemiological studies undertaken in the 1990s on Pima Indians, Egy…”
BackgroundZhong, X., Yuan, M., Li, H., Hua, L., Feng, J., Shi, J. C., Zhu, X.-R., Cao, X., & Yang, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040610 · Cited by 37
Use of Glycated Hemoglobin (A1C) in the Diagnosis of Type 2 Diabetes Mellitus in Adults
Goldenberg, R., CHENG, A. Y. Y., Punthakee, Z., & CLEMENT, M. A. (2011) · Canadian Journal of Diabetes · doi:10.1016/s1499-2671(11)53006-0 · Cited by 35
Nakagami, T., Takahashi, K., Suto, C., Oya, J., Tanaka, Y., Kurita, M., Isago, C., Hasegawa, Y., Ito, A., & Uchigata, Y. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.12.013 · Cited by 35
Peters, T. M., Holmes, M. V., Richards, J. B., Palmer, T., Forgetta, V., Lindgren, C. M., Asselbergs, F. W., Nelson, C. P., Samani, N. J., McCarthy, M. I., et al. (2020) · Diabetes Care · doi:10.2337/dc20-1137 · Cited by 35
Controversies on how diabetes is diagnosed
Malkani, S., & DeSilva, T. (2012) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32835168c0 · Cited by 35
Zhang, R., Li, Y., Zhang, S., Cai, X., Zhou, X., & Ji, L. (2016) · Journal of Diabetes Research · doi:10.1155/2016/4034129 · Cited by 35
The Correlation of Prediabetes and Type 2 Diabetes With Adiposity in Adults
Sun, J., Liu, Z., Zhang, Z., Zeng, Z., & Kang, W. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.818263 · Cited by 34
Wu, S., Yi, F.-S., Zhou, C., Zhang, M., Zhu, Y., Tuniyazi, Y., Huang, L., Huang, X., Wang, F., Bi, Y., et al. (2013) · Journal of Diabetes · doi:10.1111/1753-0407.12035 · Cited by 33
HbA1cin the Evaluation of Diabetes Mellitus
O'Keeffe, D. T., Maraka, S., & Rizza, R. A. (2016) · JAMA · doi:10.1001/jama.2015.16561 · Cited by 33
Residual dysglycemia when at target HbA1c of 7% (53mmol/mol) in persons with type 2 diabetes
Monnier, L., Colette, C., Dejager, S., & Owens, D. R. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.03.012 · Cited by 32
“[7] Colagiuri S, Lee CMY, Wong TY, Balkau B, Shaw JE, BorchJohnsen K, et al.”
BackgroundMethodInfluentialFord, C. N., Leet, R. W., Kipling, L. M., Rhee, M. K., Jackson, S. L., Wilson, P. W. F., Phillips, L. S., & Staimez, L. R. (2019) · Diabetic Medicine · doi:10.1111/dme.13979 · Cited by 31
Bereda, G., & Bereda, G. (2021) · International Archives of Endocrinology Clinical Research · doi:10.23937/2572-407x.1510024 · Cited by 31
Okosun, I. S., Annor, F., Dawodu, E. A., & Eriksen, M. P. (2014) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2014.04.026 · Cited by 31
“Mild dysglycemia” in type 2 diabetes: to be neglected or not?
Monnier, L., Colette, C., Dejager, S., & Owens, D. R. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.12.004 · Cited by 31
“The rationale for this lower HbA1c target is based on the fact that both the DETECT-2 epidemiological study (Colagiuri et al., 2011) and the interventional ADVANCE trial (Zoungas et al., 2012) have demonstrated that the prevalence of retinopathy and other microvascular complications remains low at…”
BackgroundInfluentialUnwin, N. C., Howitt, C., Rose, A., Samuels, T. A., Hennis, A. J. M., & Hambleton, I. R. (2017) · Journal of Global Health · doi:10.7189/jogh.07.020407 · Cited by 31
Dong, Y., Zhai, Y., Wang, J., Chen, Y., Xie, X., Zhang, C., Liu, J., Lu, Y., Tang, G., Han, L., et al. (2020) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-019-2704-x · Cited by 30
Lima, L. M. T. R. (2017) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765201720160394 · Cited by 30
Silverberg, E. L., Sterling, T. W., Williams, T. H., Castro, G., Rodriguez de la Vega, P., & Barengo, N. C. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18020792 · Cited by 29
Matsushita, Y., Takeda, N., Nakamura, Y., Yoshida‐Hata, N., Yamamoto, S., Noda, M., Yokoyama, T., Mizoue, T., & Nakagawa, T. (2020) · Journal of Diabetes Research · doi:10.1155/2020/3214676 · Cited by 29
Diagnostic tests: Glycated haemoglobin for the diagnosis of diabetes
dʼEmden, M. C. (2014) · Australian Prescriber · doi:10.18773/austprescr.2014.037 · Cited by 29
Standardising HbA1c-based diabetes diagnosis: opportunities and challenges
Jia, W. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2016.1133299 · Cited by 28
“a data-pooling analysis of 9 studies with 44,623 participants and observed a curvilinear relationship between HbA1c and diabetes-specific retinopathy [57].”
The Accuracy of Diagnostic Methods for Diabetic Retinopathy: A Systematic Review and Meta-Analysis
Martínez‐Vizcaíno, V., Cavero‐Redondo, I., Álvarez‐Bueno, C., & Rodríguez‐Artalejo, F. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154411 · Cited by 28
Chivese, T., Hirst, J. A., Matizanadzo, J. T., Custodio, M., Farmer, A. A., Norris, S. A., & Levitt, N. S. (2021) · Diabetic Medicine · doi:10.1111/dme.14754 · Cited by 27
Postnatal testing following gestational diabetes: time to replace the oral glucose tolerance test?
Venkataraman, H., Sattar, N. A., & Saravanan, P. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00232-6 · Cited by 27
Metadata
- Authors
- Colagiuri, S., Lee, C. M. Y., Wong, T. Y., Balkau, B., Shaw, J. E., Borch-Johnsen, K., & the DETECT-2 Collaboration Writing Group
- Affiliations
- The University of Sydney (AU)
- The University of Melbourne (AU)
- Université Paris-Sud (FR)
- Baker Heart and Diabetes Institute (AU)
- Steno Diabetes Center, Gentofte, Denmark;
- Corresponding author
- Colagiuri, Stephen
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-10-26
- Volume
- 34
- Issue
- 1
- Pages
- 145-150
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3005450
- OpenAlex
- W2134739555
- Cited by
- 300
- References
- 26
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 18 · 2023: 18 · 2022: 21 · 2021: 20 · 2020: 21 · 2019: 13 · 2018: 23 · 2017: 12 · 2016: 23 · 2015: 26 · 2014: 25 · 2013: 30 · 2012: 20
- FWCI
- 21.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-nd)
- National University of Singapore (submittedVersion)
- eSpace (Curtin University) (submittedVersion)
- Figshare (submittedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Funders
- Diabetes Australia Research Trust
- National Institutes of Health (n01hc55021-47-0-1, n01hc55020-39-0-0, n01hc55016-37-0-0, n01hc055022-024, n01hc55019-35-0-1, n01hc55018-38-0-1, n01hc55015-48-0-1)
- National Health and Medical Research Council
- National Heart, Lung, and Blood Institute (N01-HC55022, N01 HC055016, N01-HC-55018, N01 HC 55020, N01 HC 55019, N01 HC055020, N01 HC055018, N01-HC55016, N01 HC055022, N01 HC055019, N01‐HC‐55015, N01-HC55021, N01 HC055021, N01 HC055015)
- National Eye Institute
- National Institute of Diabetes and Digestive and Kidney Diseases
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Keywords
- diabetic retinopathy, glycemic thresholds, fasting blood glucose, 2-hour postprandial glucose, HbA1c, diabetes diagnostic criteria, glycemic control, fundus images
- MeSH terms
- Adult, Aged, Blood Glucose, Diabetic Retinopathy, Fasting, Glycated Hemoglobin, Humans, Middle Aged, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.